73 results on '"Thompson, Kimberly M"'
Search Results
2. Worst‐case scenarios: Modeling uncontrolled type 2 polio transmission
3. Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan
4. Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan
5. Expert Review on Poliovirus Immunity and Transmission
6. Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses
7. Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)
8. Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs
9. Modeling Poliovirus Risks and the Legacy of Polio Eradication
10. Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses
11. Preeradication Vaccine Policy Options for Poliovirus Infection and Disease Control
12. Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019–2029
13. No Role for Reintroducing OPV into the United States with Respect to Controlling COVID‐19 [Response to the letter to the Editor by Chumakov et al.]
14. An Updated Economic Analysis of the Global Polio Eradication Initiative
15. Modeling and Managing Poliovirus Risks: We are Where we are…
16. Using Animated Probability Plots to Explore the Suitability of Mixture Models with Two Component Distributions
17. Updated Characterization of Outbreak Response Strategies for 2019–2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain
18. A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID‐19 in the United States
19. Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV
20. Potential Future Use, Costs, and Value of Poliovirus Vaccines
21. Updated Characterization of Post‐OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart
22. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria
23. Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast Nigeria
24. Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame
25. Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan
26. Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame
27. Modeling Pathology Workload and Complexity to Manage Risks and Improve Patient Quality and Safety
28. Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan
29. Environmental Surveillance System Characteristics and Impacts on Confidence About No Undetected Serotype 1 Wild Poliovirus Circulation
30. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan
31. Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations
32. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases
33. Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II
34. Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part I
35. Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis
36. Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories
37. The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies
38. Modeling Measles Transmission in the North American Amish and Options for Outbreak Response
39. Systematic Review of Measles and Rubella Serology Studies
40. Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions
41. Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs)
42. Framework for Optimal Global Vaccine Stockpile Design for Vaccine‐Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples
43. Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy
44. Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses
45. Expert Review on Poliovirus Immunity and Transmission
46. Uncertainty and Sensitivity Analyses of a Decision Analytic Model for Posteradication Polio Risk Management
47. Risk Management in a Polio‐Free World
48. Poliomyelitis and the Role of Risk Analysis in Global Infectious Disease Policy and Management
49. Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network
50. Evaluation of Response Scenarios to Potential Polio Outbreaks Using Mathematical Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.